These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9185029)

  • 1. Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension.
    Fiddes R; Blumenthal J; Dawson JE; Dyckman E; St John Hammond PG; Harris S; Lasseter KC; Levine BS; Montoro R; Niederman AL; Ratner PH; Rosenblatt S; Toth PD; Vergis J; Codispoti J
    J Hum Hypertens; 1997 Apr; 11(4):239-44. PubMed ID: 9185029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension.
    Levine B; Lee W; Boyd G; Chrysant S; Dawson J; Gardner T; Hill G; Vergis J; Codispoti J; Stokes A
    J Fam Pract; 1995 Jul; 41(1):75-80. PubMed ID: 7798068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension.
    Weidler D; Jallad NS; Curry C; Ferdinand K; Jain AK; Schnaper HW; Toth PD; Codispoti J; Stokes A; McNally C
    J Clin Pharmacol; 1995 Jan; 35(1):45-51. PubMed ID: 7751412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of an oral fixed low-dose perindopril 2 MG/indapamide 0.625 MG combination: a randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension.
    Castaigne A; Chalmers J; Morgan T; Chastang C; Feldmann L; Guez D
    Clin Exp Hypertens; 1999 Oct; 21(7):1097-110. PubMed ID: 10513830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of indapamide in essential hypertension.
    Morledge JH
    Am Heart J; 1983 Jul; 106(1 Pt 2):229-32. PubMed ID: 6346846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertension.
    Hall WD; Weber MA; Ferdinand K; Flamenbaum W; Marbury T; Jain AK; Weidler D; Weiss R; Herron J; Codispoti J
    J Hum Hypertens; 1994 Aug; 8(8):571-5. PubMed ID: 7990083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension.
    Kang S; Wu YF; An N; Ren M
    Clin Ther; 2004 Feb; 26(2):257-70. PubMed ID: 15038948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Efficacy and Safety of Lower-Dose Indapamide Therapy in the Treatment of Patients with Mild to Moderate Hypertension.
    Weiss R; Toth P; Miller EE; Zellner SR; Shook M; Codispoti J; Stokes A; McNally C
    Am J Ther; 1994 Jun; 1(1):58-64. PubMed ID: 11835068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure profiles in patients treated with once-daily diltiazem extended-release or indapamide alone or in combination.
    Prisant LM;
    Am J Ther; 2000 May; 7(3):177-84. PubMed ID: 11317166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a very-low-dose combination of perindopril and indapamide--preterax compared with cilazapril monotherapy in patients with inadequate blood pressure control--a randomized, double-blind, add-on study.
    Sung SH; Wu TC; Lin SJ; Chen JW
    J Chin Med Assoc; 2008 May; 71(5):247-53. PubMed ID: 18490229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
    Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
    J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term experience with indapamide.
    Beling S; Vukovich RA; Neiss ES; Zisblatt M; Webb E; Losi M
    Am Heart J; 1983 Jul; 106(1 Pt 2):258-62. PubMed ID: 6346848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide.
    Myers MG; Asmar R; Leenen FH; Safar M
    J Hypertens; 2000 Mar; 18(3):317-25. PubMed ID: 10726719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension.
    Radevski IV; Valtchanova ZP; Candy GP; Wald AM; Ngcezula T; Sareli P
    S Afr Med J; 2002 Jul; 92(7):532-6. PubMed ID: 12197195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.